IL-6 Inhibitor

Actemra biosimilars access guide: tocilizumab IV vs SC benefit split, Tyenne/Tofidence/Avtozma payer switching, rheumatology step edits, and preferred-product policies

Actemra (tocilizumab) now faces three FDA-approved biosimilars — Tyenne (tocilizumab-aazg), Tofidence (tocilizumab-bavi), and Avtozma...